Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Increasing resistance to nalidixic acid in Shigella subgroups in a comparative study between 2001–2003 and 2004–2006
Singapore Medical Journal, 09/03/09
Mamishi S et al. – The results showed an increasing resistance of the Shigella spp., thus identifying an emergent need for an alternative agent for the treatment of shigellosis in future.
Related Articles
Antibiotic therapy for Shigella dysentery
Cochrane Reviews, 10/22/09
Relevance Score: 88%
Characterization of Shigella sonnei isolates from travel-associated cases in Japan
Journal of Medical Microbiology, 10/22/09
Relevance Score: 83%
Bcl-2 Regulates the Onset of Shiga toxin 1-induced Apoptosis in THP-1 cells
Infection and Immunity, 10/05/09
Relevance Score: 80%
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Selection and counterselection of the adefovir resistance mutation rtI233V during antiviral therapy
Journal of Clinical Microbiology, 12/18/09
Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer
Medical Oncology, 12/18/09
Epidemiology and Evolution of Invasive Pneumococcal Disease Caused by Multidrug Resistant Serotypes of 19A in the 8 Years After Implementation of Pneumococcal Conjugate Vaccine Immunization in Dallas, Texas
The Pediatric Infectious Disease Journal, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


